OpenAlex
PricingAboutJobs
Log inGet started
Work

A Phase II Study of Troglitazone, an Activator of the PPAR?? Receptor, in Patients with Chemotherapy-Resistant Metastatic Colorectal Cancer

HTML

Year: 2002
Type: article
Study design: Clinical Trial
Source: The Cancer Journal
DOI: 10.1097/00130404-200209000-00010
Authors: Matthew H. Kulke, George D. Demetri, Norman E. Sharpless, David P. Ryan, Ramesh Shivdasani, Jeffrey S. Clark, Bruce M. Spiegelman, Haesook Kim, Robert J. Mayer, Charles S. Fuchs
Institutions: Dana-Farber Cancer Institute, UNC Lineberger Comprehensive Cancer Center, Harvard University, Massachusetts General Hospital
Language: English

Topic: Peroxisome Proliferator-Activated Receptors
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: troglitazone, PPARγ, metastatic colorectal cancer, chemoresistance, oral anticancer drugs, tumor differentiation, treatment toxicity, progression-free survival, survival
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2056734036
FWCI: 2.264
Cites: 18
Cited by: 169
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security